Neurotech International Limited
ASX:NTI.AX
0.053 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.002 | 0.006 | 0.038 | 0.206 | 0.077 | 0.195 | 0.03 | 0.088 | 0.127 |
| Cost of Revenue
| 0.008 | 0.002 | 0.573 | 0.445 | 0.624 | 1.353 | 0.087 | 0.258 | 0.548 |
| Gross Profit
| -0.006 | 0.004 | -0.535 | -0.239 | -0.546 | -1.158 | -0.057 | -0.17 | -0.421 |
| Gross Profit Ratio
| -2.989 | 0.707 | -13.988 | -1.158 | -7.063 | -5.953 | -1.897 | -1.923 | -3.325 |
| Reseach & Development Expenses
| 5.247 | 6.453 | 2.578 | 5.358 | 0 | 0.02 | 0.29 | 0.243 | 0.028 |
| General & Administrative Expenses
| 2.378 | 0.949 | 0.71 | 0.67 | 0.66 | 1.176 | 1.055 | 1.221 | 0.506 |
| Selling & Marketing Expenses
| 0 | 0.011 | 0.012 | 0.013 | 0.018 | 0.203 | 0.116 | 0.114 | 0.05 |
| SG&A
| 3.507 | 2.57 | 0.807 | 1.899 | 0.724 | 1.485 | 2.6 | 2.886 | 1.366 |
| Other Expenses
| -0.008 | 1.198 | 0.569 | 0.051 | 0 | 0.048 | 0.037 | -0.063 | 0 |
| Operating Expenses
| 8.762 | 9.023 | 3.385 | 7.207 | 0.724 | 1.505 | 3.945 | 3.845 | 1.366 |
| Operating Income
| -8.761 | -9.018 | -3.92 | -7.445 | -1.27 | -2.663 | -3.749 | -3.892 | -1.787 |
| Operating Income Ratio
| -4,462.939 | -1,513.423 | -102.453 | -36.117 | -16.414 | -13.686 | -124.778 | -44.069 | -14.106 |
| Total Other Income Expenses Net
| 0.516 | 0.038 | -0.012 | 0.015 | -0.444 | -2.14 | -0.241 | -0.14 | -0.395 |
| Income Before Tax
| -8.245 | -8.98 | -3.932 | -7.431 | -1.713 | -4.802 | -3.99 | -4.032 | -2.181 |
| Income Before Tax Ratio
| -4,200.011 | -1,507.043 | -102.754 | -36.046 | -22.147 | -24.683 | -132.802 | -45.655 | -17.221 |
| Income Tax Expense
| -3.175 | -1.189 | -0.569 | -7.448 | -0 | -0.002 | -0.405 | -0.237 | 0 |
| Net Income
| -5.069 | -7.792 | -3.362 | -7.431 | -1.713 | -4.802 | -3.99 | -4.032 | -2.181 |
| Net Income Ratio
| -2,582.4 | -1,307.592 | -87.874 | -36.046 | -22.147 | -24.683 | -132.802 | -45.655 | -17.221 |
| EPS
| -0.006 | -0.01 | -0.005 | -0.015 | -0.011 | -0.041 | -0.039 | -0.054 | -0.032 |
| EPS Diluted
| -0.006 | -0.01 | -0.005 | -0.015 | -0.011 | -0.041 | -0.039 | -0.054 | -0.032 |
| EBITDA
| -8.76 | -9.017 | -3.919 | -7.445 | -1.189 | -2.663 | -3.624 | -3.766 | -1.666 |
| EBITDA Ratio
| -4,462.644 | -1,513.131 | -102.438 | -36.117 | -15.366 | -13.686 | -120.608 | -42.644 | -13.155 |